Immunohistochemical Expression of BRCA1 and Lethal Prostate Cancer
- 14 April 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (8) , 3136-3139
Abstract
BRCA1 functions as a tumor suppressor; recent work suggests that BRCA1 may also induce cell cycle arrest to allow for DNA repair. We hypothesized that BRCA1 expression in prostate tumor tissue may be associated with prostate cancer progression through regulation of the cell cycle. We used immunohistochemistry to evaluate BRCA1 protein expression in archival tumor samples from 393 prostate cancer cases in the Physicians' Health Study. The men were followed prospectively from diagnosis to development of metastases and mortality. Fifteen percent of tumors stained positive for BRCA1. BRCA1-positive tumors had substantially increased tumor proliferation index compared with negative tumors (47.0 Ki67-positive nuclei versus 10.3, P = 0.0016) and were more likely to develop lethal cancer compared with BRCA1-negative tumors (hazard ratio, 4.6; 95% confidence interval, 2.4–8.7). These findings strengthen the hypothesis that BRCA1 plays a role in cell cycle control and show that BRCA1 is a marker of clinical prostate cancer prognosis. Cancer Res; 70(8); 3136–9. ©2010 AACR.Keywords
This publication has 21 references indexed in Scilit:
- Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?Journal of Clinical Oncology, 2009
- Prostate Cancer Progression and Survival in BRCA2 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2007
- Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, CanadaJNCI: Journal of the National Cancer Institute, 2006
- The role of BRCA1 in transcriptional regulation and cell cycle controlOncogene, 2006
- Ki-67 Staining Is a Strong Predictor of Distant Metastasis and Mortality for Men With Prostate Cancer Treated With Radiotherapy Plus Androgen Deprivation: Radiation Therapy Oncology Group Trial 92–02Journal of Clinical Oncology, 2004
- BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene ExpressionJournal of Biological Chemistry, 2000
- Stable Interaction between the Products of the BRCA1 and BRCA2 Tumor Suppressor Genes in Mitotic and Meiotic CellsMolecular Cell, 1998
- A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells.1997
- Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA DamageCell, 1997
- A randomized trial of aspirin and β-carotene among U.S. physiciansPreventive Medicine, 1985